Literature DB >> 31325016

The clinical and radiological profile of primary lateral sclerosis: a population-based study.

Eoin Finegan1, Rangariroyashe H Chipika1, Stacey Li Hi Shing1, Mark A Doherty2, Jennifer C Hengeveld2, Alice Vajda2, Colette Donaghy3, Russell L McLaughlin2, Niall Pender1,4, Orla Hardiman1, Peter Bede5.   

Abstract

BACKGROUND: Primary lateral sclerosis is a progressive upper-motor-neuron disorder associated with markedly longer survival than ALS. In contrast to ALS, the genetic susceptibility, histopathological profile and imaging signature of PLS are poorly characterised. Suspected PLS patients often face considerable diagnostic delay and prognostic uncertainty.
OBJECTIVE: To characterise the distinguishing clinical, genetic and imaging features of PLS in contrast to ALS and healthy controls.
METHODS: A prospective population-based study was conducted with 49 PLS patients, 100 ALS patients and 100 healthy controls using genetic profiling, standardised clinical assessments and neuroimaging. Whole-brain and region-of-interest analyses were undertaken to evaluate patterns of grey and white matter degeneration.
RESULTS: In PLS, disease burden in the motor cortex is more medial than in ALS consistent with its lower limb symptom-predominance. PLS is associated with considerable cerebellar white and grey matter degeneration and the extra-motor profile of PLS includes marked insular, inferior frontal and left pars opercularis pathology. Contrary to ALS, PLS spares the postcentral gyrus. The body and splenium of the corpus callosum are preferentially affected in PLS, in contrast to the genu involvement observed in ALS. Clinical measures show anatomically meaningful correlations with imaging metrics in a somatotopic distribution. PLS patients tested negative for C9orf72 repeat expansions, known ALS and HSP-associated genes.
CONCLUSIONS: Multiparametric imaging in PLS highlights disease-specific motor and extra-motor involvement distinct from ALS. In a condition where limited post-mortem data are available, imaging offers invaluable pathological insights. Anatomical correlations with clinical metrics confirm the biomarker potential of quantitative neuroimaging in PLS.

Entities:  

Keywords:  Amyotrophic lateral sclerosis; Genetics; MRI; Neuroimaging; Primary lateral sclerosis

Mesh:

Substances:

Year:  2019        PMID: 31325016     DOI: 10.1007/s00415-019-09473-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  73 in total

1.  Multiparametric MRI study of ALS stratified for the C9orf72 genotype.

Authors:  Peter Bede; Arun L W Bokde; Susan Byrne; Marwa Elamin; Russell L McLaughlin; Kevin Kenna; Andrew J Fagan; Niall Pender; Daniel G Bradley; Orla Hardiman
Journal:  Neurology       Date:  2013-06-14       Impact factor: 9.910

Review 2.  Presymptomatic and longitudinal neuroimaging in neurodegeneration--from snapshots to motion picture: a systematic review.

Authors:  Christina Schuster; Marwa Elamin; Orla Hardiman; Peter Bede
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-01-28       Impact factor: 10.154

3.  Stages of pTDP-43 pathology in amyotrophic lateral sclerosis.

Authors:  Johannes Brettschneider; Kelly Del Tredici; Jon B Toledo; John L Robinson; David J Irwin; Murray Grossman; EunRan Suh; Vivianna M Van Deerlin; Elisabeth M Wood; Young Baek; Linda Kwong; Edward B Lee; Lauren Elman; Leo McCluskey; Lubin Fang; Simone Feldengut; Albert C Ludolph; Virginia M-Y Lee; Heiko Braak; John Q Trojanowski
Journal:  Ann Neurol       Date:  2013-06-19       Impact factor: 10.422

4.  Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients.

Authors:  Petra Steinacker; Emily Feneberg; Jochen Weishaupt; Johannes Brettschneider; Hayrettin Tumani; Peter M Andersen; Christine A F von Arnim; Sarah Böhm; Jan Kassubek; Christian Kubisch; Dorothée Lulé; Hans-Peter Müller; Rainer Muche; Elmar Pinkhardt; Patrick Oeckl; Angela Rosenbohm; Sarah Anderl-Straub; Alexander E Volk; Patrick Weydt; Albert C Ludolph; Markus Otto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-08-21       Impact factor: 10.154

5.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

Authors:  J M Cedarbaum; N Stambler; E Malta; C Fuller; D Hilt; B Thurmond; A Nakanishi
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

6.  Screening for cognitive dysfunction in ALS: validation of the Edinburgh Cognitive and Behavioural ALS Screen (ECAS) using age and education adjusted normative data.

Authors:  Marta Pinto-Grau; Tom Burke; Katie Lonergan; Caroline McHugh; Iain Mays; Caoifa Madden; Alice Vajda; Mark Heverin; Marwa Elamin; Orla Hardiman; Niall Pender
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2016-11-28       Impact factor: 4.092

7.  Investigating the neuroanatomical substrate of pathological laughing and crying in amyotrophic lateral sclerosis with multimodal neuroimaging techniques.

Authors:  Foteini Christidi; Efstratios Karavasilis; Panagiotis Ferentinos; Sophia Xirou; Georgios Velonakis; Michalis Rentzos; Vasiliki Zouvelou; Ioannis Zalonis; Efstathios Efstathopoulos; Nikolaos Kelekis; Ioannis Evdokimidis
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2017-10-15       Impact factor: 4.092

Review 8.  Evidence for topographic organization in the cerebellum of motor control versus cognitive and affective processing.

Authors:  Catherine J Stoodley; Jeremy D Schmahmann
Journal:  Cortex       Date:  2010-01-11       Impact factor: 4.027

9.  Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.

Authors:  Takayuki Kosaka; Yong-Juan Fu; Atsushi Shiga; Haruka Ishidaira; Chun-Feng Tan; Takashi Tani; Ryoko Koike; Osamu Onodera; Masatoyo Nishizawa; Akiyoshi Kakita; Hitoshi Takahashi
Journal:  Neuropathology       Date:  2011-11-21       Impact factor: 1.906

10.  Cerebro-cerebellar connectivity is increased in primary lateral sclerosis.

Authors:  Avner Meoded; Arthur E Morrissette; Rohan Katipally; Olivia Schanz; Stephen J Gotts; Mary Kay Floeter
Journal:  Neuroimage Clin       Date:  2014-12-09       Impact factor: 4.881

View more
  25 in total

Review 1.  The imaging signature of C9orf72 hexanucleotide repeat expansions: implications for clinical trials and therapy development.

Authors:  Stacey Li Hi Shing; Mary Clare McKenna; We Fong Siah; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-01-05       Impact factor: 3.978

2.  Time-trend evolution and determinants of sex ratio in Amyotrophic Lateral Sclerosis: a dose-response meta-analysis.

Authors:  Andrea Fontana; Benoit Marin; Jaime Luna; Ettore Beghi; Giancarlo Logroscino; Farid Boumédiene; Pierre-Marie Preux; Philippe Couratier; Massimilano Copetti
Journal:  J Neurol       Date:  2021-02-25       Impact factor: 4.849

3.  Extra-motor manifestations in post-polio syndrome (PPS): fatigue, cognitive symptoms and radiological features.

Authors:  Stacey Li Hi Shing; Jasmin Lope; Rangariroyashe H Chipika; Orla Hardiman; Peter Bede
Journal:  Neurol Sci       Date:  2021-02-26       Impact factor: 3.307

Review 4.  The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?

Authors:  Rangariroyashe H Chipika; We Fong Siah; Mary Clare McKenna; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2020-10-31       Impact factor: 6.682

5.  Imaging and clinical data indicate considerable disease burden in 'probable' PLS: Patients with UMN symptoms for 2-4 years.

Authors:  Eoin Finegan; We Fong Siah; Stacey Li Hi Shing; Rangariroyashe H Chipika; Kai Ming Chang; Mary Clare McKenna; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Colette Donaghy; Siobhan Hutchinson; Russel L McLaughlin; Orla Hardiman; Peter Bede
Journal:  Data Brief       Date:  2020-09-01

6.  Longitudinal evaluation of upper motor neuron burden scales in primary lateral sclerosis.

Authors:  Mary Kay Floeter; Tianxia Wu
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2020-07-13       Impact factor: 4.092

7.  Cortical progression patterns in individual ALS patients across multiple timepoints: a mosaic-based approach for clinical use.

Authors:  Marlene Tahedl; Rangariroyashe H Chipika; Jasmin Lope; Stacey Li Hi Shing; Orla Hardiman; Peter Bede
Journal:  J Neurol       Date:  2021-01-05       Impact factor: 4.849

Review 8.  Upper Motor Neuron Disorders: Primary Lateral Sclerosis, Upper Motor Neuron Dominant Amyotrophic Lateral Sclerosis, and Hereditary Spastic Paraplegia.

Authors:  Timothy Fullam; Jeffrey Statland
Journal:  Brain Sci       Date:  2021-05-11

9.  Initial Cerebellar Ataxia in Hereditary Adult-Onset Primary Lateral Sclerosis.

Authors:  José Gazulla; Silvia Izquierdo-Alvarez; Emilio Ruiz-Fernández; José Berciano
Journal:  Case Rep Neurol       Date:  2021-06-21

10.  Clusters of anatomical disease-burden patterns in ALS: a data-driven approach confirms radiological subtypes.

Authors:  Peter Bede; Aizuri Murad; Jasmin Lope; Orla Hardiman; Kai Ming Chang
Journal:  J Neurol       Date:  2022-03-25       Impact factor: 6.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.